Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease

被引:4
|
作者
Buoso, Chiara [1 ,2 ]
Seifert, Markus [2 ,3 ]
Lang, Martin [1 ]
Griffith, Corey M. [4 ]
Andujar, Begon Talavera [4 ]
Rueda, Maria Paulina Castelo [1 ]
Fischer, Christine [2 ]
Doerrier, Carolina [6 ]
Talasz, Heribert [5 ]
Zanon, Alessandra [1 ]
Pramstaller, Peter P. [1 ]
Schymanski, Emma L. [4 ]
Pichler, Irene [1 ]
Weiss, Guenter [2 ,3 ]
机构
[1] Eurac Res, Inst Biomed, I-39100 Bolzano, Italy
[2] Med Univ Innsbruck, Dept Internal Med 2, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, A-6020 Innsbruck, Austria
[4] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4362 Belvaux, Luxembourg
[5] Med Univ Innsbruck, Inst Med Biochem, Prot Core Facil, Bioctr Innsbruck, A-6020 Innsbruck, Austria
[6] Oroboros Instruments, A-6020 Innsbruck, Austria
基金
欧盟地平线“2020”;
关键词
Parkinson's disease; Iron; Dopamine; Mitochondrial function; hiPSC-derived neurons; MULTIPLE SYSTEM ATROPHY; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; COMPLEX I; METABOLISM; DYSFUNCTION; NEURONS; CELLS; BRAIN; ACID;
D O I
10.1016/j.nbd.2024.106506
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Imbalances of iron and dopamine metabolism along with mitochondrial dysfunction have been linked to the pathogenesis of Parkinson ' s disease (PD). We have previously suggested a direct link between iron homeostasis and dopamine metabolism, as dopamine can increase cellular uptake of iron into macrophages thereby promoting oxidative stress responses. In this study, we investigated the interplay between iron, dopamine, and mitochondrial activity in neuroblastoma SH-SY5Y cells and human induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons differentiated from a healthy control and a PD patient with a mutation in the alpha-synuclein ( SNCA ) gene. In SH-SY5Y cells, dopamine treatment resulted in increased expression of the transmembrane iron transporters transferrin receptor 1 (TFR1), ferroportin (FPN), and mitoferrin2 (MFRN2) and intracellular iron accumulation, suggesting that dopamine may promote iron uptake. Furthermore, dopamine supplementation led to reduced mitochondrial fitness including decreased mitochondrial respiration, increased cytochrome c control efficiency, reduced mtDNA copy number and citrate synthase activity, increased oxidative stress and impaired aconitase activity. In dopaminergic neurons derived from a healthy control individual, dopamine showed comparable effects as observed in SH-SY5Y cells. The hiPSC-derived PD neurons harboring an endogenous SNCA mutation demonstrated altered mitochondrial iron homeostasis, reduced mitochondrial capacity along with increased oxidative stress and alterations of tricarboxylic acid cycle linked metabolic pathways compared with control neurons. Importantly, dopamine treatment of PD neurons promoted a rescue effect by increasing mitochondrial respiration, activating antioxidant stress response, and normalizing altered metabolite levels linked to mitochondrial function. These observations provide evidence that dopamine affects iron homeostasis, intracellular stress responses and mitochondrial function in healthy cells, while dopamine supplementation can restore the disturbed regulatory network in PD cells.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] On the Role of Iron in Idiopathic Parkinson's Disease
    Huenchuguala, Sandro
    Segura-Aguilar, Juan
    BIOMEDICINES, 2023, 11 (11)
  • [22] Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
    Tapias, Victor
    Gonzalez-Andres, Paula
    Pena, Laura F.
    Barbero, Asuncion
    Nunez, Lucia
    Villalobos, Carlos
    ANTIOXIDANTS, 2023, 12 (06)
  • [23] Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease
    Haddad, Dominik
    Nakamura, Ken
    FEBS LETTERS, 2015, 589 (24): : 3702 - 3713
  • [24] The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
    Li, Hong-Yan
    Liu, De-Shui
    Zhang, Ying-Bo
    Rong, Hua
    Zhang, Xiao-Jie
    BIOPHYSICAL CHEMISTRY, 2023, 303
  • [25] Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson's disease
    Teferi, Nahom
    Challa, Meron
    Woodiwiss, Timothy
    Allen, Bryan
    Petronek, Michael
    REDOX EXPERIMENTAL MEDICINE, 2023, 2023 (01):
  • [26] Intranasal delivery of mitochondrial protein humanin rescues cell death and promotes mitochondrial function in Parkinson's disease
    Kim, Kyung Hwa
    THERANOSTICS, 2023, 13 (10): : 3330 - 3345
  • [27] Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
    Wise, Rachel M.
    Wagener, Annika
    Fietzek, Urban M.
    Klopstock, Thomas
    Mosharov, Eugene V.
    Zucca, Fabio A.
    Sulzer, David
    Zecca, Luigi
    Burbulla, Lena F.
    NEUROBIOLOGY OF DISEASE, 2022, 175
  • [28] Pomegranate Juice Ameliorates Dopamine Release and Behavioral Deficits in a Rat Model of Parkinson's Disease
    Kujawska, Malgorzata
    Jourdes, Michael
    Witucki, Lukasz
    Karazniewicz-Lada, Marta
    Szulc, Michal
    Gorska, Agata
    Mikolajczak, Przemyslaw L.
    Teissedre, Pierre-Louis
    Jodynis-Liebert, Jadwiga
    BRAIN SCIENCES, 2021, 11 (09)
  • [29] Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis
    Alberio, Tiziana
    Bondi, Heather
    Colombo, Flavia
    Alloggio, Isabella
    Pieroni, Luisa
    Urbani, Andrea
    Fasano, Mauro
    MOLECULAR BIOSYSTEMS, 2014, 10 (06) : 1332 - 1344
  • [30] Role of dopamine in the pathophysiology of Parkinson's disease
    Zhou, Zhi Dong
    Yi, Ling Xiao
    Wang, Dennis Qing
    Lim, Tit Meng
    Tan, Eng King
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)